[1]
|
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. and Thun, M.J. (2009) Cancer statistics. CA: A Cancer Journal for Clinicians, 59, 225-249.
|
[2]
|
World Health Organization (2006) Cancer. Fact Sheet (No. 297), Geneva.
http://www.who.int/mediacentre/factsheets/fs297/en/print.html
|
[3]
|
National Cancer Institute (2002) Administrative and statistical report for NCI, 2002-2008. www.nci.edu.eg
|
[4]
|
National Cancer Institute (2008) Administrative and statistical report for NCI. http://www.nci.edu.eg
|
[5]
|
Leung, Y.K., Mak, P., Hassan, S., et al. (2006) Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling. Proceedings of the National Academy of Sciences of the United States of America, 103, 13162-13167.
doi:10.1073/pnas.0605676103
|
[6]
|
Campbell-Thompson, M., Lynch, I. and Bhardwaj, B. (2001) Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Research, 61, 632-640.
|
[7]
|
Mueller, S.O. and Korach, K.S. (2001) Estrogen receptors and endocrine diseases: Lessons from estrogen receptor knockout mice. Current Opinion in Pharmacology, 1, 613-619.
|
[8]
|
Björnström, L. and Sjöberg, M. (2005) Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Molecular Endocrinology, 19, 833-842.
|
[9]
|
Konstantinopoulos, P.A., Kominea, A., Vandoros, G., et al. (2003) Oestrogen receptor β (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation. European Journal of Cancer, 39, 1251-1258.
doi:10.1016/S0959-8049(03)00239-9
|
[10]
|
Harnish, D., Albert, L., Leathurby, Y. et al. (2004) Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. American Journal of Physiology Gastrointestinal and Liver Physiology, 286, 118-125. doi:10.1152/ajpgi.00024.2003
|
[11]
|
Gustfsson, J.-Å. (2006) ERβ scientific visions translate to clinical uses. Climacteric, 9, 156-160.
doi:10.1080/14689360600734328
|
[12]
|
Harris, H.A. (2007) Estrogen receptor-β: Recent lessons from in vivo studies. Molecular Endocrinology, 21, 1-13.
doi:10.1210/me.2005-0459
|
[13]
|
Galluzzo, P., Caiazza, F., Moreno, S., et al. (2007) Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocrine-Related Cancer, 14, 153-167. doi:10.1677/ERC-06-0020
|
[14]
|
Di Leo, A., Barone, M., Maiorano, E., et al. (2008) ERbeta expression in large bowel adenomas: Implications in colon carcinogenesis. Digestive and Liver Disease, 40, 260-266. doi:10.1016/j.dld.2007.10.018
|
[15]
|
Fletcher, R.H. (2000) Screening for colorectal cancer: Strategies in patients at average risk.
http://www.uptodate.com/contents/screening-for-colorectal-cancer-strategies-in-patients-at-average-risk
|
[16]
|
National Cancer Institute (2009) Cancer.
http://www.cancer.gov/cancertopics/commoncancers
|
[17]
|
Campbell-Thompson, M., Lynch, I. and Bhardwaj, B. (2001) Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Research, 61, 632-640.
|
[18]
|
Konstantinopoulos, P.A., Kominea, A., Vandoros, G., et al. (2003) Oestrogen receptor β (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation. European Journal of Cancer, 39, 1251-1258.
doi:10.1016/S0959-8049(03)00239-9
|
[19]
|
Xie, L.Q., Yu, J.P. and Luo, H.S. (2004) Expression of estrogen receptor β in human colorectal cancer. World Journal of Gastroenterology, 10, 214-217.
|
[20]
|
Ferlay, J., Bray, F., Pisani, P., et al. (2005) Cancer incidence, mortality and prevalence worldwide. CA: A Cancer Journal for Clinicians, 55, 74-108.
|
[21]
|
El Attar, I. (2005) Colo-rectal cancer: Magnitude of the problem. Annual cancer. Conference of the Egyptian Cancer Society, Danish Cancer Society & Aarhus University Hospital, Cairo, 9-11 February.
|
[22]
|
Mc Leod, H. and Murray, G. (1999) Tumor markers of prognosis in colorectal cancer. British Journal of Cancer, 79, 191-203. doi:10.1038/sj.bjc.6690033
|
[23]
|
Bond, J. (2000) Colorectal cancer update. Prevention, screening, treatment, and surveillance for high risk groups. Medical Clinics of North America, 84, 1163-1182.
doi:10.1016/S0025-7125(05)70281-9
|
[24]
|
Zakaria, M.S., Hashem, A., Abdelbary, M.S., et al. (2006) The pattern of colonic diseases in Egypt: A colonoscopic study. Arab Journal of Gastroenterology, 7, 53-58.
|
[25]
|
Winawer, S.J., Fletcher, R., Rex, D., et al. (2003) Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology, 124, 544. doi:10.1053/gast.2003.50044
|
[26]
|
Deans, G.T., Patterson, C.C., Parks, T.G., et al. (1994) Colorectal carcinoma: Importance of clinical and pathological factors in survival. Annals of the Royal College of Surgeons of England, 76, 59-64.
|
[27]
|
Kanazawa, T., Watanabe, T., Kazama, S., et al. (2002) Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. International Journal of Cancer, 102, 225-229. doi:10.1002/ijc.10690
|
[28]
|
Slattery, M.L., Samowitz, W.S. and Holden, J.A. (2000) Estrogen and progesterone receptors in colon tumors. American Journal of Clinical Pathology, 113, 364-368.
doi:10.1309/5MHB-K6XX-QV50-PCJQ
|
[29]
|
Ekem, T.E., Bahadir, B., Gun, B.D., et al. (2008) Colorectal carcinomas: Clinicopathologic investigation, correlation with expression of estrogen and progesterone receptors. Turkish Journal of Cancer, 38, 118-122.
|
[30]
|
Dawson, P., Shousha, S., Blair, S., et al. (1990) Oestrogen receptors in colorectal carcinoma. Journal of Clinical Pathology, 43, 149-151. doi:10.1136/jcp.43.2.149
|
[31]
|
Foley, E.F., Jazaeri, A.A., Shupnik, M.A., et al. (2000) Selective loss of estrogen receptor β in malignant human colon. Cancer Research, 60, 245-248.
|
[32]
|
Qiu, Y., Waters, C., Lewis, A., et al. (2002) Oestrogeninduced apoptosis in colonocytes expressing oestrogen receptor beta. Journal of Endocrinology, 174, 369-377.
doi:10.1677/joe.0.1740369
|
[33]
|
Wada-Hiraike, O., Imamov, O., Hiraike, H., et al. (2006) Role of estrogen receptor β in colonic epithelium. Proceedings of the National Academy of Sciences of the United States of America, 103, 2959-2964.
doi:10.1073/pnas.0511271103
|
[34]
|
Witte, D., Chirala, M., Younes, A., et al. (2001) Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Human Pathology, 32, 940-944.
doi:10.1053/hupa.2001.27117
|
[35]
|
Galluzzo, P., Caiazza, F., Moreno, S., et al. (2007) Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocrine-Related Cancer, 14, 153-167. doi:10.1677/ERC-06-0020
|
[36]
|
Concolino, G., Arrabito, G., Buonomo, O., et al. (1986) Nuclear steroid receptors and dysplasia in adenomatous polyps of the colon as markers of high risk for malignant transformation. Cancer Detection and Prevention Journal, 9, 477-484.
|
[37]
|
Di Leo, A., Barone, M., Maiorano, E., et al. (2008) ERbeta expression in large bowel adenomas: Implications in colon carcinogenesis. Digestive and Liver Disease, 40, 260-266. doi:10.1016/j.dld.2007.10.018
|
[38]
|
Zakaria, M.S., Abdel-Bary, M.S., Said, M., Yosry, Ay., Seif, M. and Hindawy A. (2007) Evaluation of estrogen receptors in malignant and premalignant colorectal lesions. Egyptian journal of Medical Sciences, 28, 12.
|
[39]
|
Shen, R.L., Tao, L.H., Xu, Y.Q., Chang, S., Van Brocklyn, J. and Gao, J.-X. (2009) Reversibility of aberrant global DNA and estrogen receptor-α gene methylation distinguishes colorectal precancer from cancer. International Journal of Clinical and Experimental Pathology, 2, 21-33.
|